With its robust balance sheet, a large acquisition by Thermo Fisher within the fragmented life science industry would not be surprising, an Evercore ISI analyst says. Over the past few years, the life science industry has seen continual disruption and consolidation through M&A activity, but according to Evercore ISI analyst Ross Muken the space remains fragmented. Muken noted this following a breakfast meeting with Marc Casper, CEO of Thermo Fisher. Thermo Fisher has been one of – if not –…